Smith+Nephew · 1 week ago
Director, Health Economics & Market Access (HEMA) - Policy, Advocacy & Strategy
United States
Full-time
Remote
Director/Executive
$140K/yr - $235K/yr
10+ years expSmith+Nephew is a company that designs and manufactures technology to enhance living. The Director, Health Economics & Market Access (HEMA) – Policy, Advocacy & Strategy is responsible for shaping reimbursement policy and strategy to ensure patient access and commercial success, leading initiatives that influence payer and legislative outcomes.
BiotechnologyHealthcareMedical DeviceHealth CareMedical
Responsibilities
Lead end-to-end reimbursement strategy development for pipeline and pre-launch products, including assessment of coding, coverage, and payment pathways
Identify reimbursement risks and opportunities at the portfolio level and inform go/no-go, sequencing, and investment decisions
Develop multi-year reimbursement roadmaps aligned with product lifecycle milestones and enterprise growth objectives
Serve as the internal expert on future reimbursement pathways and access readiness
Shape and execute an integrated reimbursement policy and advocacy strategy in partnership with Government Affairs and senior leadership
Monitor, analyze, and influence CMS rulemaking, Medicare payment policy, and broader healthcare policy developments impacting device reimbursement
Represent the organization in trade associations, coalitions, and policy forums to advance industry positions and reimbursement priorities
Engage with external stakeholders, including professional societies and key opinion leaders, to support favorable coverage and payment environments
Partner with Government Affairs to engage policymakers and regulatory agencies
Identify and proactively mitigate policy risks that could impact access, adoption, or value recognition
Partner with Clinical, Medical Affairs, and HEOR teams to define payer-relevant clinical and economic evidence requirements
Ensure reimbursement and policy needs are embedded into evidence generation strategies, endpoints, and real-world data plans
Provide strategic guidance on value narratives and positioning aligned to payer and policy decision drivers
Advise executive leadership on reimbursement and policy trends, risks, and strategic implications
Establish governance frameworks and tools to embed reimbursement and advocacy considerations into enterprise planning
Lead cross-functional initiatives through influence in a highly matrixed organization
Qualification
Required
Bachelor's degree required
10+ years of experience in medical device reimbursement, market access, or health policy
Demonstrated experience influencing Medicare policy, reimbursement frameworks, and/or industry advocacy efforts
Strong executive presence with the ability to translate complex policy issues into clear business impact
Proven ability to lead strategically within a highly matrixed environment
Preferred
advanced degree (MPH, MBA, MHA, MS)
Benefits
401k Matching Program
401k Plus Program
Employee Stock Purchase Plan
Tuition Reimbursement
Flexible Personal/Vacation Time Off
Paid Holidays
Flex Holidays
Paid Community Service Day
Medical, Dental, Vision, Health Savings Account (Employer Contribution of $500+ annually)
Employee Assistance Program
Parental Leave
Fertility and Adoption Assistance Program
Hybrid Work Model (For most professional roles)
Hands-On, Team-Customized, Mentorship
Discounts on fitness clubs, travel and more!
Medical, dental, and vision coverage
401k
Tuition reimbursement
Medical leave programs
Parental leave
Generous PTO
Paid company holidays annually
8 hours of Volunteer time
A variety of wellness offerings such as EAP
Company
Smith+Nephew
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Cevian Capital
2026-07-27Post Ipo Equity· $1.67B
1999-11-26IPO
Leadership Team
Ian Bennett
Director of Information Technology
Recent News
2026-08-05
2026-08-04
MarketScreener
2026-08-04
Company data provided by crunchbase